data_2fsp_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2fsp _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 mtm . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -170.01 37.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.359 -0.838 . . . . 0.0 109.42 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -97.89 45.87 1.02 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.206 -0.934 . . . . 0.0 109.518 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -99.66 50.76 0.93 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.198 -0.939 . . . . 0.0 109.473 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.75 152.63 18.94 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 109.462 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 55.6 mt -149.73 157.77 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.242 -0.911 . . . . 0.0 109.465 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.484 ' C ' ' CD1' ' A' ' 7' ' ' LEU . 1.8 tm? -130.49 109.71 10.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.295 -0.878 . . . . 0.0 109.544 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 10.4 mt -91.08 102.55 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.256 -0.902 . . . . 0.0 109.453 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.9 t -90.06 104.25 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.242 -0.911 . . . . 0.0 109.486 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.514 ' O ' ' CD ' ' A' ' 16' ' ' ARG . 6.2 t70 -154.5 123.41 6.28 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.253 -0.905 . . . . 0.0 109.515 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -88.25 -37.38 16.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.258 -0.901 . . . . 0.0 109.493 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -66.21 132.74 49.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.208 -0.933 . . . . 0.0 109.517 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.556 ' CE1' ' CD1' ' A' ' 17' ' ' ILE . 17.1 t80 -70.61 142.48 51.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.229 -0.92 . . . . 0.0 109.447 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 124.5 -43.31 1.41 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.4 mt -82.34 -47.78 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -1.125 . . . . 0.0 109.468 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.514 ' CD ' ' O ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -60.49 -22.77 63.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.267 -0.896 . . . . 0.0 109.518 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.556 ' CD1' ' CE1' ' A' ' 13' ' ' TYR . 10.7 mm -90.12 -59.98 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 0.0 109.589 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.36 -58.52 6.8 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.197 -0.939 . . . . 0.0 109.603 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.9 mp -55.92 -25.28 42.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.191 -0.943 . . . . 0.0 109.616 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.504 ' OD1' ' ND2' ' A' ' 24' ' ' ASN . 22.6 t30 -71.44 -71.57 0.26 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.259 -0.901 . . . . 0.0 109.556 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 20' ' ' ASN . 3.4 mt-10 -43.82 -39.5 3.87 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 0.0 109.551 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.415 ' CG2' ' CG2' ' A' ' 108' ' ' ILE . 87.2 t -61.02 -54.35 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.183 -0.948 . . . . 0.0 109.553 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 21.0 m-85 -79.36 3.4 18.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.327 -0.858 . . . . 0.0 109.601 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.504 ' ND2' ' OD1' ' A' ' 20' ' ' ASN . 0.4 OUTLIER -90.06 -44.87 9.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.185 -0.947 . . . . 0.0 109.447 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -83.96 -35.58 23.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.249 -0.907 . . . . 0.0 109.51 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.62 -22.14 64.99 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.199 -0.938 . . . . 0.0 109.468 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.569 ' O ' ' CG ' ' A' ' 28' ' ' TYR . . . 100.42 76.49 1.23 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.569 ' CG ' ' O ' ' A' ' 27' ' ' GLY . 96.5 m-85 -160.06 134.94 7.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.28 -1.13 . . . . 0.0 109.494 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -93.16 81.46 4.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.348 -0.845 . . . . 0.0 109.442 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.9 p -90.11 151.7 21.48 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.34 -0.85 . . . . 0.0 109.472 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -114.41 -169.76 1.6 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.25 -0.906 . . . . 0.0 109.418 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -130.03 141.73 50.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.19 -0.943 . . . . 0.0 109.475 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.506 ' O ' ' CB ' ' A' ' 34' ' ' ALA . . . -153.51 -170.27 3.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 109.471 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.506 ' CB ' ' O ' ' A' ' 33' ' ' ALA . . . 164.06 -44.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.905 . . . . 0.0 109.494 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.404 ' OD1' ' CB ' ' A' ' 38' ' ' GLN . 22.1 p-10 -65.94 -9.87 33.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.283 -0.886 . . . . 0.0 109.445 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.54 -51.85 3.65 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -31.37 72.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.23 -1.159 . . . . 0.0 109.498 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.504 ' O ' ' CD1' ' A' ' 42' ' ' ILE . 6.2 tp-100 -70.0 -35.37 74.33 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.255 -0.903 . . . . 0.0 109.461 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.406 ' O ' ' CG2' ' A' ' 43' ' ' VAL . . . -69.02 -47.24 65.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -0.885 . . . . 0.0 109.495 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 43.5 mt -62.29 -39.74 93.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 0.0 109.45 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.84 -56.07 25.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.301 -0.874 . . . . 0.0 109.522 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.504 ' CD1' ' O ' ' A' ' 38' ' ' GLN . 2.5 mt -60.44 -22.07 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.297 -0.877 . . . . 0.0 109.481 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 39' ' ' ALA . 79.8 t -79.21 -29.98 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.488 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 36.7 m -89.97 -16.34 30.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.195 -0.941 . . . . 0.0 109.448 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -90.03 -39.49 12.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.253 -0.904 . . . . 0.0 109.517 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -112.17 -32.81 6.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.927 . . . . 0.0 109.499 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 47.2 mtm180 61.1 72.47 0.69 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 109.459 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.96 175.82 10.73 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.638 2.226 . . . . 0.0 110.472 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -113.38 -10.78 13.23 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.263 -0.898 . . . . 0.0 109.447 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.2 tp -124.79 122.33 37.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.279 -0.888 . . . . 0.0 109.452 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 94.7 t -128.35 118.83 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 109.431 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -90.04 103.36 16.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.245 -0.91 . . . . 0.0 109.486 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.39 133.5 39.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.23 -0.919 . . . . 0.0 109.416 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -117.97 130.51 56.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.244 -0.91 . . . . 0.0 109.47 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' MET . . . . . . . . . . . . . 16.9 mmt -84.39 10.88 9.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.228 -0.92 . . . . 0.0 109.493 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 57' ' ' ILE . 20.2 mmtt -85.38 -25.34 27.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.203 -0.935 . . . . 0.0 109.436 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.52 ' CG2' ' CE ' ' A' ' 60' ' ' MET . 44.2 mt -42.63 102.75 0.28 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.347 -0.846 . . . . 0.0 109.598 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.98 71.79 6.47 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.474 2.116 . . . . 0.0 110.368 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -163.65 -37.7 0.02 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' MET . . . . . 0.52 ' CE ' ' CG2' ' A' ' 57' ' ' ILE . 0.1 OUTLIER -167.73 137.74 2.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.31 -1.112 . . . . 0.0 109.434 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -57.87 136.06 56.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.286 -0.884 . . . . 0.0 109.463 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.07 10.31 61.02 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 27.9 mm -62.0 -38.44 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.174 -1.192 . . . . 0.0 109.459 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -68.51 -41.75 79.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.182 -0.949 . . . . 0.0 109.452 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 10.4 mt -50.54 -54.58 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.237 -0.914 . . . . 0.0 109.477 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.524 ' O ' ' CG ' ' A' ' 70' ' ' LYS . 22.9 mt -49.88 -41.59 45.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.245 -0.91 . . . . 0.0 109.498 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.501 ' O ' ' CG2' ' A' ' 71' ' ' VAL . 17.2 mttt -56.26 -51.19 69.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.276 -0.89 . . . . 0.0 109.518 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -56.41 -38.98 72.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.268 -0.895 . . . . 0.0 109.392 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 3.4 mtt -65.86 -31.5 72.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.287 -0.883 . . . . 0.0 109.461 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.524 ' CG ' ' O ' ' A' ' 66' ' ' LEU . 1.9 mttt -81.49 -17.86 47.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 109.221 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.501 ' CG2' ' O ' ' A' ' 67' ' ' LYS . 2.6 t -90.06 -25.13 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.293 -0.879 . . . . 0.0 109.541 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 9.4 mt -90.04 -38.8 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.222 -0.924 . . . . 0.0 109.446 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -150.95 136.51 17.9 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.3 -0.875 . . . . 0.0 109.465 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -89.59 -16.93 29.51 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.183 -0.948 . . . . 0.0 109.479 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -95.48 37.66 1.18 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.198 -0.939 . . . . 0.0 109.5 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -100.12 141.64 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.27 -0.894 . . . . 0.0 109.441 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.423 ' C ' ' CG2' ' A' ' 78' ' ' VAL . 62.8 mtt180 -109.42 147.56 32.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.267 -0.896 . . . . 0.0 109.488 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.423 ' CG2' ' C ' ' A' ' 77' ' ' ARG . 1.8 t -151.18 134.98 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.194 -0.941 . . . . 0.0 109.514 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 80.5 mt -109.23 156.26 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.294 -0.879 . . . . 0.0 109.511 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.48 ' O ' ' N ' ' A' ' 102' ' ' PHE . 0.7 OUTLIER -108.24 112.12 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.254 -0.904 . . . . 0.0 109.369 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 21.8 mtm -90.0 52.3 2.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.26 -0.9 . . . . 0.0 109.381 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.525 ' O ' ' CG2' ' A' ' 82' ' ' THR . 15.1 t -166.74 62.31 0.09 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.258 -0.901 . . . . 0.0 109.49 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.633 ' CB ' ' CD2' ' A' ' 101' ' ' HIS . . . -87.02 -18.32 30.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.25 -0.906 . . . . 0.0 109.465 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -90.0 75.88 7.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.27 -0.894 . . . . 0.0 109.472 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -173.4 -103.14 0.16 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -114.61 173.57 6.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.29 -1.123 . . . . 0.0 109.437 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 5.1 mp -147.56 69.98 1.16 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.228 -0.92 . . . . 0.0 109.442 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.01 -80.61 0.42 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.258 -0.901 . . . . 0.0 109.497 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.462 ' O ' ' CB ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -84.05 10.28 10.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.203 -0.935 . . . . 0.0 109.458 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.623 ' CD1' ' CE1' ' A' ' 101' ' ' HIS . 2.8 tt -74.32 -44.71 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.284 -0.885 . . . . 0.0 109.466 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.445 ' N ' ' CG2' ' A' ' 90' ' ' ILE . 1.2 tt0 -57.04 -60.35 3.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -0.886 . . . . 0.0 109.48 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -62.98 -32.71 74.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.268 -0.895 . . . . 0.0 109.43 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.462 ' CB ' ' O ' ' A' ' 89' ' ' MET . 2.2 m -60.41 -23.8 64.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.202 -0.936 . . . . 0.0 109.484 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.5 tttt -66.38 -70.33 0.25 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -0.921 . . . . 0.0 109.475 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -54.0 -19.54 4.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.265 -0.897 . . . . 0.0 109.396 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 46.4 mt -70.51 -62.33 1.43 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 0.0 109.505 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -175.32 31.41 0.09 OUTLIER Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -101.93 92.88 5.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.184 -1.186 . . . . 0.0 109.465 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 21.5 mt -45.5 -77.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.256 -0.903 . . . . 0.0 109.484 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.2 t -122.37 179.4 4.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.166 -0.959 . . . . 0.0 109.474 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.633 ' CD2' ' CB ' ' A' ' 83' ' ' ALA . 4.4 t60 -134.83 93.69 3.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.283 -0.886 . . . . 0.0 109.445 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.624 ' CD2' ' CD1' ' A' ' 111' ' ' ILE . 9.2 m-85 -82.77 154.42 24.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -0.928 . . . . 0.0 109.486 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -129.88 -169.91 2.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.282 -0.886 . . . . 0.0 109.398 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 46.5 tttt -124.94 141.38 38.17 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.191 -0.943 . . . . 0.0 109.38 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.07 139.04 54.24 Favored 'Cis proline' 0 C--N 1.311 -1.439 0 C-N-CA 123.383 -1.507 . . . . 0.0 110.332 0.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -105.8 173.24 6.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.318 -0.864 . . . . 0.0 109.563 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -112.28 125.15 53.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.336 -0.852 . . . . 0.0 109.491 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.415 ' CG2' ' CG2' ' A' ' 22' ' ' VAL . 15.1 mm -52.53 -20.59 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.437 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -75.25 -40.86 58.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.251 -0.906 . . . . 0.0 109.439 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.69 -31.06 66.37 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.218 -0.926 . . . . 0.0 109.502 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.624 ' CD1' ' CD2' ' A' ' 102' ' ' PHE . 28.7 mm -70.19 -53.76 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.331 -0.856 . . . . 0.0 109.508 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 9.3 ptt180 -65.96 -29.18 69.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.88 . . . . 0.0 109.505 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -66.43 -51.54 55.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 0.0 109.434 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.575 ' O ' ' CD2' ' A' ' 118' ' ' TYR . . . -64.97 -33.86 77.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.28 -0.887 . . . . 0.0 109.489 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 55.1 t -68.8 -31.89 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.917 . . . . 0.0 109.502 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.1 mmmt -74.03 -46.22 44.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.318 -0.864 . . . . 0.0 109.463 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -61.5 -40.55 95.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.295 -0.878 . . . . 0.0 109.489 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' TYR . . . . . 0.575 ' CD2' ' O ' ' A' ' 114' ' ' ALA . 21.5 m-85 -68.85 -70.59 0.26 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.203 -0.936 . . . . 0.0 109.47 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.2 tp -90.13 112.55 53.08 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.235 -0.916 . . . . 0.0 109.427 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.97 134.89 13.56 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.388 2.059 . . . . 0.0 110.387 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.457 ' O ' ' O ' ' A' ' 122' ' ' LYS . 5.6 mt -89.83 164.64 14.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.53 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 121' ' ' LEU . 0.8 OUTLIER -46.62 172.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.208 -0.932 . . . . 0.0 109.424 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.7 p -50.63 114.61 1.19 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 109.47 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.481 179.979 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 mtm . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -170.01 37.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.359 -0.838 . . . . 0.0 109.42 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -97.89 45.87 1.02 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.206 -0.934 . . . . 0.0 109.518 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -99.66 50.76 0.93 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.198 -0.939 . . . . 0.0 109.473 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.467 ' HB2' ' HB3' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -97.75 152.63 18.94 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 109.462 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.469 ' HB ' ' HA ' ' A' ' 30' ' ' THR . 55.6 mt -149.73 157.77 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.242 -0.911 . . . . 0.0 109.465 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.723 HD12 HG22 ' A' ' 9' ' ' VAL . 1.8 tm? -130.49 109.71 10.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.295 -0.878 . . . . 0.0 109.544 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.55 ' N ' HD13 ' A' ' 7' ' ' LEU . 10.4 mt -91.08 102.55 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.256 -0.902 . . . . 0.0 109.453 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.723 HG22 HD12 ' A' ' 7' ' ' LEU . 2.9 t -90.06 104.25 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.242 -0.911 . . . . 0.0 109.486 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.514 ' O ' ' CD ' ' A' ' 16' ' ' ARG . 6.2 t70 -154.5 123.41 6.28 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.253 -0.905 . . . . 0.0 109.515 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.478 ' OD2' ' HD2' ' A' ' 58' ' ' PRO . 6.7 p-10 -88.25 -37.38 16.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.258 -0.901 . . . . 0.0 109.493 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -66.21 132.74 49.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.208 -0.933 . . . . 0.0 109.517 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.82 ' CE1' HD11 ' A' ' 17' ' ' ILE . 17.1 t80 -70.61 142.48 51.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.229 -0.92 . . . . 0.0 109.447 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.46 ' O ' HD12 ' A' ' 18' ' ' LEU . . . 124.5 -43.31 1.41 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 1.001 HG23 HD13 ' A' ' 19' ' ' LEU . 2.4 mt -82.34 -47.78 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -1.125 . . . . 0.0 109.468 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.514 ' CD ' ' O ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -60.49 -22.77 63.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.267 -0.896 . . . . 0.0 109.518 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.82 HD11 ' CE1' ' A' ' 13' ' ' TYR . 10.7 mm -90.12 -59.98 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 0.0 109.589 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.558 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -53.36 -58.52 6.8 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.197 -0.939 . . . . 0.0 109.603 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 1.001 HD13 HG23 ' A' ' 15' ' ' ILE . 4.9 mp -55.92 -25.28 42.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.191 -0.943 . . . . 0.0 109.616 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 16' ' ' ARG . 22.6 t30 -71.44 -71.57 0.26 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.259 -0.901 . . . . 0.0 109.556 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.482 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 3.4 mt-10 -43.82 -39.5 3.87 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 0.0 109.551 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.65 HG21 ' CG2' ' A' ' 108' ' ' ILE . 87.2 t -61.02 -54.35 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.183 -0.948 . . . . 0.0 109.553 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.612 ' CZ ' HG21 ' A' ' 115' ' ' VAL . 21.0 m-85 -79.36 3.4 18.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.327 -0.858 . . . . 0.0 109.601 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.482 ' HB2' ' HA ' ' A' ' 21' ' ' GLU . 1.0 OUTLIER -90.06 -44.87 9.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.185 -0.947 . . . . 0.0 109.447 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -83.96 -35.58 23.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.249 -0.907 . . . . 0.0 109.51 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.62 -22.14 64.99 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.199 -0.938 . . . . 0.0 109.468 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.569 ' O ' ' CG ' ' A' ' 28' ' ' TYR . . . 100.42 76.49 1.23 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.569 ' CG ' ' O ' ' A' ' 27' ' ' GLY . 96.5 m-85 -160.06 134.94 7.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.28 -1.13 . . . . 0.0 109.494 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -93.16 81.46 4.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.348 -0.845 . . . . 0.0 109.442 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.552 HG21 ' CB ' ' A' ' 23' ' ' PHE . 5.9 p -90.11 151.7 21.48 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.34 -0.85 . . . . 0.0 109.472 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.63 ' HB2' HD22 ' A' ' 7' ' ' LEU . 9.2 m-85 -114.41 -169.76 1.6 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.25 -0.906 . . . . 0.0 109.418 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -130.03 141.73 50.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.19 -0.943 . . . . 0.0 109.475 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.702 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -153.51 -170.27 3.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 109.471 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.702 ' HB2' ' O ' ' A' ' 33' ' ' ALA . . . 164.06 -44.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.905 . . . . 0.0 109.494 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.416 ' OD1' ' HB2' ' A' ' 38' ' ' GLN . 22.1 p-10 -65.94 -9.87 33.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.283 -0.886 . . . . 0.0 109.445 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.54 -51.85 3.65 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -31.37 72.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.23 -1.159 . . . . 0.0 109.498 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 1.055 ' O ' HD12 ' A' ' 42' ' ' ILE . 36.0 tp60 -70.0 -35.37 74.33 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.255 -0.903 . . . . 0.0 109.461 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.82 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -69.02 -47.24 65.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -0.885 . . . . 0.0 109.495 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.458 HD22 ' HB3' ' A' ' 68' ' ' ARG . 43.5 mt -62.29 -39.74 93.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 0.0 109.45 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.84 -56.07 25.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.301 -0.874 . . . . 0.0 109.522 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 1.055 HD12 ' O ' ' A' ' 38' ' ' GLN . 2.5 mt -60.44 -22.07 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.297 -0.877 . . . . 0.0 109.481 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 39' ' ' ALA . 79.8 t -79.21 -29.98 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.488 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 36.7 m -89.97 -16.34 30.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.195 -0.941 . . . . 0.0 109.448 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -90.03 -39.49 12.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.253 -0.904 . . . . 0.0 109.517 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' A' ' 47' ' ' ARG . 22.9 mm-40 -112.17 -32.81 6.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.927 . . . . 0.0 109.499 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 43' ' ' VAL . 47.2 mtm180 61.1 72.47 0.69 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 109.459 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.467 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 35.7 Cg_endo -77.96 175.82 10.73 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.638 2.226 . . . . 0.0 110.472 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 1.9 m-20 -113.38 -10.78 13.23 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.263 -0.898 . . . . 0.0 109.447 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.775 HD21 HG22 ' A' ' 115' ' ' VAL . 12.2 tp -124.79 122.33 37.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.279 -0.888 . . . . 0.0 109.452 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 94.7 t -128.35 118.83 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 109.431 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.436 ' CD1' HG12 ' A' ' 8' ' ' ILE . 1.0 OUTLIER -90.04 103.36 16.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.245 -0.91 . . . . 0.0 109.486 179.917 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.664 HD22 ' CD2' ' A' ' 66' ' ' LEU . 1.0 OUTLIER -95.39 133.5 39.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.23 -0.919 . . . . 0.0 109.416 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.427 ' HB2' ' CE ' ' A' ' 81' ' ' MET . 35.6 t0 -117.97 130.51 56.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.244 -0.91 . . . . 0.0 109.47 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' MET . . . . . 0.991 ' HB2' HG21 ' A' ' 82' ' ' THR . 16.9 mmt -84.39 10.88 9.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.228 -0.92 . . . . 0.0 109.493 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.438 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 20.2 mmtt -85.38 -25.34 27.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.203 -0.935 . . . . 0.0 109.436 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.967 HG21 ' HE1' ' A' ' 60' ' ' MET . 44.2 mt -42.63 102.75 0.28 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.347 -0.846 . . . . 0.0 109.598 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.478 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 35.7 Cg_endo -77.98 71.79 6.47 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.474 2.116 . . . . 0.0 110.368 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -163.65 -37.7 0.02 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' MET . . . . . 0.967 ' HE1' HG21 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -167.73 137.74 2.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.31 -1.112 . . . . 0.0 109.434 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -57.87 136.06 56.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.286 -0.884 . . . . 0.0 109.463 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.07 10.31 61.02 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 27.9 mm -62.0 -38.44 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.174 -1.192 . . . . 0.0 109.459 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 67' ' ' LYS . 1.1 mt-10 -68.51 -41.75 79.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.182 -0.949 . . . . 0.0 109.452 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.413 HG22 ' HE2' ' A' ' 69' ' ' MET . 10.4 mt -50.54 -54.58 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.237 -0.914 . . . . 0.0 109.477 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.753 HD21 HG11 ' A' ' 78' ' ' VAL . 22.9 mt -49.88 -41.59 45.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.245 -0.91 . . . . 0.0 109.498 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 1.001 ' O ' HG23 ' A' ' 71' ' ' VAL . 17.2 mttt -56.26 -51.19 69.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.276 -0.89 . . . . 0.0 109.518 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.458 ' HB3' HD22 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -56.41 -38.98 72.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.268 -0.895 . . . . 0.0 109.392 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.413 ' HE2' HG22 ' A' ' 65' ' ' ILE . 3.4 mtt -65.86 -31.5 72.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.287 -0.883 . . . . 0.0 109.461 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.524 ' CG ' ' O ' ' A' ' 66' ' ' LEU . 1.9 mttt -81.49 -17.86 47.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 109.221 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 1.001 HG23 ' O ' ' A' ' 67' ' ' LYS . 2.6 t -90.06 -25.13 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.293 -0.879 . . . . 0.0 109.541 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 68' ' ' ARG . 9.4 mt -90.04 -38.8 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.222 -0.924 . . . . 0.0 109.446 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -150.95 136.51 17.9 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.3 -0.875 . . . . 0.0 109.465 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -89.59 -16.93 29.51 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.183 -0.948 . . . . 0.0 109.479 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -95.48 37.66 1.18 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.198 -0.939 . . . . 0.0 109.5 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.513 HG13 ' N ' ' A' ' 77' ' ' ARG . 0.5 OUTLIER -100.12 141.64 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.27 -0.894 . . . . 0.0 109.441 -179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.611 ' CG ' HD11 ' A' ' 99' ' ' LEU . 62.8 mtt180 -109.42 147.56 32.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.267 -0.896 . . . . 0.0 109.488 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.753 HG11 HD21 ' A' ' 66' ' ' LEU . 1.8 t -151.18 134.98 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.194 -0.941 . . . . 0.0 109.514 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.833 HG12 HG22 ' A' ' 100' ' ' THR . 80.5 mt -109.23 156.26 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.294 -0.879 . . . . 0.0 109.511 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.91 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.7 OUTLIER -108.24 112.12 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.254 -0.904 . . . . 0.0 109.369 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.427 ' CE ' ' HB2' ' A' ' 54' ' ' ASP . 21.8 mtm -90.0 52.3 2.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.26 -0.9 . . . . 0.0 109.381 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.991 HG21 ' HB2' ' A' ' 55' ' ' MET . 15.1 t -166.74 62.31 0.09 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.258 -0.901 . . . . 0.0 109.49 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.986 ' HB2' ' CD2' ' A' ' 101' ' ' HIS . . . -87.02 -18.32 30.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.25 -0.906 . . . . 0.0 109.465 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -90.0 75.88 7.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.27 -0.894 . . . . 0.0 109.472 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -173.4 -103.14 0.16 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.529 ' C ' HD12 ' A' ' 87' ' ' LEU . 11.5 pt-20 -114.61 173.57 6.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.29 -1.123 . . . . 0.0 109.437 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.529 HD12 ' C ' ' A' ' 86' ' ' GLU . 5.1 mp -147.56 69.98 1.16 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.228 -0.92 . . . . 0.0 109.442 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.01 -80.61 0.42 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.258 -0.901 . . . . 0.0 109.497 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.462 ' O ' ' CB ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -84.05 10.28 10.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.203 -0.935 . . . . 0.0 109.458 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.623 ' CD1' ' CE1' ' A' ' 101' ' ' HIS . 2.8 tt -74.32 -44.71 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.284 -0.885 . . . . 0.0 109.466 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.584 ' N ' HG23 ' A' ' 90' ' ' ILE . 1.2 tt0 -57.04 -60.35 3.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -0.886 . . . . 0.0 109.48 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.46 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 7.8 mt-10 -62.98 -32.71 74.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.268 -0.895 . . . . 0.0 109.43 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.964 ' HA ' HD12 ' A' ' 96' ' ' LEU . 2.2 m -60.41 -23.8 64.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.202 -0.936 . . . . 0.0 109.484 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.833 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 16.5 tttt -66.38 -70.33 0.25 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -0.921 . . . . 0.0 109.475 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -54.0 -19.54 4.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.265 -0.897 . . . . 0.0 109.396 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.964 HD12 ' HA ' ' A' ' 93' ' ' SER . 46.4 mt -70.51 -62.33 1.43 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 0.0 109.505 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -175.32 31.41 0.09 OUTLIER Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.833 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -101.93 92.88 5.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.184 -1.186 . . . . 0.0 109.465 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.611 HD11 ' CG ' ' A' ' 77' ' ' ARG . 21.5 mt -45.5 -77.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.256 -0.903 . . . . 0.0 109.484 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.833 HG22 HG12 ' A' ' 79' ' ' ILE . 12.2 t -122.37 179.4 4.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.166 -0.959 . . . . 0.0 109.474 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.986 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 4.4 t60 -134.83 93.69 3.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.283 -0.886 . . . . 0.0 109.445 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.695 ' CD2' HD13 ' A' ' 111' ' ' ILE . 9.2 m-85 -82.77 154.42 24.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -0.928 . . . . 0.0 109.486 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.855 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -129.88 -169.91 2.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.282 -0.886 . . . . 0.0 109.398 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.483 ' CG ' ' HA ' ' A' ' 105' ' ' PRO . 46.5 tttt -124.94 141.38 38.17 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.191 -0.943 . . . . 0.0 109.38 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.483 ' HA ' ' CG ' ' A' ' 104' ' ' LYS . 35.3 Cg_endo -78.07 139.04 54.24 Favored 'Cis proline' 0 C--N 1.311 -1.439 0 C-N-CA 123.383 -1.507 . . . . 0.0 110.332 0.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.44 ' HB3' ' O ' ' A' ' 103' ' ' ALA . 0.3 OUTLIER -105.8 173.24 6.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.318 -0.864 . . . . 0.0 109.563 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -112.28 125.15 53.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.336 -0.852 . . . . 0.0 109.491 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.65 ' CG2' HG21 ' A' ' 22' ' ' VAL . 15.1 mm -52.53 -20.59 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.437 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -75.25 -40.86 58.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.251 -0.906 . . . . 0.0 109.439 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.69 -31.06 66.37 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.218 -0.926 . . . . 0.0 109.502 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.695 HD13 ' CD2' ' A' ' 102' ' ' PHE . 28.7 mm -70.19 -53.76 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.331 -0.856 . . . . 0.0 109.508 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 9.3 ptt180 -65.96 -29.18 69.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.88 . . . . 0.0 109.505 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -66.43 -51.54 55.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 0.0 109.434 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.575 ' O ' ' CD2' ' A' ' 118' ' ' TYR . . . -64.97 -33.86 77.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.28 -0.887 . . . . 0.0 109.489 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.775 HG22 HD21 ' A' ' 50' ' ' LEU . 55.1 t -68.8 -31.89 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.917 . . . . 0.0 109.502 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.1 mmmt -74.03 -46.22 44.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.318 -0.864 . . . . 0.0 109.463 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -61.5 -40.55 95.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.295 -0.878 . . . . 0.0 109.489 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' TYR . . . . . 0.575 ' CD2' ' O ' ' A' ' 114' ' ' ALA . 21.5 m-85 -68.85 -70.59 0.26 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.203 -0.936 . . . . 0.0 109.47 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.2 tp -90.13 112.55 53.08 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.235 -0.916 . . . . 0.0 109.427 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 35.8 Cg_endo -77.97 134.89 13.56 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.388 2.059 . . . . 0.0 110.387 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.47 HD23 ' HA ' ' A' ' 121' ' ' LEU . 5.6 mt -89.83 164.64 14.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.53 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 121' ' ' LEU . 0.8 OUTLIER -46.62 172.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.208 -0.932 . . . . 0.0 109.424 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.7 p -50.63 114.61 1.19 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 109.47 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.481 179.979 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.3 mtm . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -170.01 37.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.359 -0.838 . . . . 0.0 109.42 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -97.89 45.87 1.02 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.206 -0.934 . . . . 0.0 109.518 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -99.66 50.76 0.93 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.198 -0.939 . . . . 0.0 109.473 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.467 ' HB2' ' HB3' ' A' ' 48' ' ' PRO . 0.0 OUTLIER -97.75 152.63 18.94 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.252 -0.905 . . . . 0.0 109.462 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.469 ' HB ' ' HA ' ' A' ' 30' ' ' THR . 55.6 mt -149.73 157.77 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.242 -0.911 . . . . 0.0 109.465 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.723 HD12 HG22 ' A' ' 9' ' ' VAL . 1.8 tm? -130.49 109.71 10.9 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.295 -0.878 . . . . 0.0 109.544 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.55 ' N ' HD13 ' A' ' 7' ' ' LEU . 10.4 mt -91.08 102.55 13.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.256 -0.902 . . . . 0.0 109.453 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.723 HG22 HD12 ' A' ' 7' ' ' LEU . 2.9 t -90.06 104.25 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.242 -0.911 . . . . 0.0 109.486 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.514 ' O ' ' CD ' ' A' ' 16' ' ' ARG . 6.2 t70 -154.5 123.41 6.28 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.253 -0.905 . . . . 0.0 109.515 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.478 ' OD2' ' HD2' ' A' ' 58' ' ' PRO . 6.7 p-10 -88.25 -37.38 16.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.258 -0.901 . . . . 0.0 109.493 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -66.21 132.74 49.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.208 -0.933 . . . . 0.0 109.517 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.82 ' CE1' HD11 ' A' ' 17' ' ' ILE . 17.1 t80 -70.61 142.48 51.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.229 -0.92 . . . . 0.0 109.447 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.46 ' O ' HD12 ' A' ' 18' ' ' LEU . . . 124.5 -43.31 1.41 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.524 -1.431 . . . . 0.0 109.524 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 1.001 HG23 HD13 ' A' ' 19' ' ' LEU . 2.4 mt -82.34 -47.78 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -1.125 . . . . 0.0 109.468 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.514 ' CD ' ' O ' ' A' ' 10' ' ' ASP . 0.0 OUTLIER -60.49 -22.77 63.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.267 -0.896 . . . . 0.0 109.518 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.82 HD11 ' CE1' ' A' ' 13' ' ' TYR . 10.7 mm -90.12 -59.98 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.175 -0.953 . . . . 0.0 109.589 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.558 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.2 OUTLIER -53.36 -58.52 6.8 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.197 -0.939 . . . . 0.0 109.603 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 1.001 HD13 HG23 ' A' ' 15' ' ' ILE . 4.9 mp -55.92 -25.28 42.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.191 -0.943 . . . . 0.0 109.616 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.504 ' OD1' ' ND2' ' A' ' 24' ' ' ASN . 22.6 t30 -71.44 -71.57 0.26 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.259 -0.901 . . . . 0.0 109.556 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.482 ' HA ' ' HB2' ' A' ' 24' ' ' ASN . 3.4 mt-10 -43.82 -39.5 3.87 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.283 -0.886 . . . . 0.0 109.551 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.65 HG21 ' CG2' ' A' ' 108' ' ' ILE . 87.2 t -61.02 -54.35 36.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.183 -0.948 . . . . 0.0 109.553 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.612 ' CZ ' HG21 ' A' ' 115' ' ' VAL . 21.0 m-85 -79.36 3.4 18.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.327 -0.858 . . . . 0.0 109.601 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.504 ' ND2' ' OD1' ' A' ' 20' ' ' ASN . 0.4 OUTLIER -90.06 -44.87 9.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.185 -0.947 . . . . 0.0 109.447 -179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -83.96 -35.58 23.87 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.249 -0.907 . . . . 0.0 109.51 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.62 -22.14 64.99 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.199 -0.938 . . . . 0.0 109.468 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.569 ' O ' ' CG ' ' A' ' 28' ' ' TYR . . . 100.42 76.49 1.23 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.569 ' CG ' ' O ' ' A' ' 27' ' ' GLY . 96.5 m-85 -160.06 134.94 7.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.28 -1.13 . . . . 0.0 109.494 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -93.16 81.46 4.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.348 -0.845 . . . . 0.0 109.442 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.552 HG21 ' CB ' ' A' ' 23' ' ' PHE . 5.9 p -90.11 151.7 21.48 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.34 -0.85 . . . . 0.0 109.472 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.63 ' HB2' HD22 ' A' ' 7' ' ' LEU . 9.2 m-85 -114.41 -169.76 1.6 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.25 -0.906 . . . . 0.0 109.418 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -130.03 141.73 50.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.19 -0.943 . . . . 0.0 109.475 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.702 ' O ' ' HB2' ' A' ' 34' ' ' ALA . . . -153.51 -170.27 3.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 109.471 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.702 ' HB2' ' O ' ' A' ' 33' ' ' ALA . . . 164.06 -44.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.253 -0.905 . . . . 0.0 109.494 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.416 ' OD1' ' HB2' ' A' ' 38' ' ' GLN . 22.1 p-10 -65.94 -9.87 33.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.283 -0.886 . . . . 0.0 109.445 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 89.54 -51.85 3.65 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -66.58 -31.37 72.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.23 -1.159 . . . . 0.0 109.498 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 1.055 ' O ' HD12 ' A' ' 42' ' ' ILE . 6.2 tp-100 -70.0 -35.37 74.33 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.255 -0.903 . . . . 0.0 109.461 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.82 ' O ' HG23 ' A' ' 43' ' ' VAL . . . -69.02 -47.24 65.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -0.885 . . . . 0.0 109.495 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.458 HD22 ' HB3' ' A' ' 68' ' ' ARG . 43.5 mt -62.29 -39.74 93.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.239 -0.913 . . . . 0.0 109.45 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.84 -56.07 25.56 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.301 -0.874 . . . . 0.0 109.522 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 1.055 HD12 ' O ' ' A' ' 38' ' ' GLN . 2.5 mt -60.44 -22.07 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.297 -0.877 . . . . 0.0 109.481 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.82 HG23 ' O ' ' A' ' 39' ' ' ALA . 79.8 t -79.21 -29.98 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.249 -0.907 . . . . 0.0 109.488 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 36.7 m -89.97 -16.34 30.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.195 -0.941 . . . . 0.0 109.448 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.7 mttt -90.03 -39.49 12.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.253 -0.904 . . . . 0.0 109.517 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' A' ' 47' ' ' ARG . 22.9 mm-40 -112.17 -32.81 6.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.927 . . . . 0.0 109.499 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 43' ' ' VAL . 47.2 mtm180 61.1 72.47 0.69 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.239 -0.913 . . . . 0.0 109.459 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.467 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 35.7 Cg_endo -77.96 175.82 10.73 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.638 2.226 . . . . 0.0 110.472 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.448 ' O ' ' HB2' ' A' ' 77' ' ' ARG . 1.9 m-20 -113.38 -10.78 13.23 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.263 -0.898 . . . . 0.0 109.447 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.775 HD21 HG22 ' A' ' 115' ' ' VAL . 12.2 tp -124.79 122.33 37.13 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.279 -0.888 . . . . 0.0 109.452 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 78' ' ' VAL . 94.7 t -128.35 118.83 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.284 -0.885 . . . . 0.0 109.431 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.436 ' CD1' HG12 ' A' ' 8' ' ' ILE . 1.0 OUTLIER -90.04 103.36 16.03 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.245 -0.91 . . . . 0.0 109.486 179.917 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.664 HD22 ' CD2' ' A' ' 66' ' ' LEU . 1.0 OUTLIER -95.39 133.5 39.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.23 -0.919 . . . . 0.0 109.416 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.427 ' HB2' ' CE ' ' A' ' 81' ' ' MET . 35.6 t0 -117.97 130.51 56.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.244 -0.91 . . . . 0.0 109.47 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' MET . . . . . 0.991 ' HB2' HG21 ' A' ' 82' ' ' THR . 16.9 mmt -84.39 10.88 9.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.228 -0.92 . . . . 0.0 109.493 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.438 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 20.2 mmtt -85.38 -25.34 27.12 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.203 -0.935 . . . . 0.0 109.436 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.967 HG21 ' HE1' ' A' ' 60' ' ' MET . 44.2 mt -42.63 102.75 0.28 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.347 -0.846 . . . . 0.0 109.598 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.478 ' HD2' ' OD2' ' A' ' 11' ' ' ASP . 35.7 Cg_endo -77.98 71.79 6.47 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.474 2.116 . . . . 0.0 110.368 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -163.65 -37.7 0.02 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' MET . . . . . 0.967 ' HE1' HG21 ' A' ' 57' ' ' ILE . 0.1 OUTLIER -167.73 137.74 2.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.31 -1.112 . . . . 0.0 109.434 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 -57.87 136.06 56.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.286 -0.884 . . . . 0.0 109.463 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -84.07 10.31 61.02 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 27.9 mm -62.0 -38.44 80.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.174 -1.192 . . . . 0.0 109.459 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.467 ' O ' ' HB2' ' A' ' 67' ' ' LYS . 1.1 mt-10 -68.51 -41.75 79.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.182 -0.949 . . . . 0.0 109.452 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.413 HG22 ' HE2' ' A' ' 69' ' ' MET . 10.4 mt -50.54 -54.58 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.237 -0.914 . . . . 0.0 109.477 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.753 HD21 HG11 ' A' ' 78' ' ' VAL . 22.9 mt -49.88 -41.59 45.92 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.245 -0.91 . . . . 0.0 109.498 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 1.001 ' O ' HG23 ' A' ' 71' ' ' VAL . 17.2 mttt -56.26 -51.19 69.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.276 -0.89 . . . . 0.0 109.518 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.458 ' HB3' HD22 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -56.41 -38.98 72.26 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.268 -0.895 . . . . 0.0 109.392 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.413 ' HE2' HG22 ' A' ' 65' ' ' ILE . 3.4 mtt -65.86 -31.5 72.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.287 -0.883 . . . . 0.0 109.461 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.524 ' CG ' ' O ' ' A' ' 66' ' ' LEU . 1.9 mttt -81.49 -17.86 47.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.277 -0.889 . . . . 0.0 109.221 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 1.001 HG23 ' O ' ' A' ' 67' ' ' LYS . 2.6 t -90.06 -25.13 5.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.293 -0.879 . . . . 0.0 109.541 -179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 68' ' ' ARG . 9.4 mt -90.04 -38.8 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.222 -0.924 . . . . 0.0 109.446 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -150.95 136.51 17.9 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.3 -0.875 . . . . 0.0 109.465 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -89.59 -16.93 29.51 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.183 -0.948 . . . . 0.0 109.479 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -95.48 37.66 1.18 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.198 -0.939 . . . . 0.0 109.5 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.513 HG13 ' N ' ' A' ' 77' ' ' ARG . 0.5 OUTLIER -100.12 141.64 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.27 -0.894 . . . . 0.0 109.441 -179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.611 ' CG ' HD11 ' A' ' 99' ' ' LEU . 62.8 mtt180 -109.42 147.56 32.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.267 -0.896 . . . . 0.0 109.488 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.753 HG11 HD21 ' A' ' 66' ' ' LEU . 1.8 t -151.18 134.98 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.194 -0.941 . . . . 0.0 109.514 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.833 HG12 HG22 ' A' ' 100' ' ' THR . 80.5 mt -109.23 156.26 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.294 -0.879 . . . . 0.0 109.511 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.91 HD12 ' ND1' ' A' ' 101' ' ' HIS . 0.7 OUTLIER -108.24 112.12 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.254 -0.904 . . . . 0.0 109.369 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.427 ' CE ' ' HB2' ' A' ' 54' ' ' ASP . 21.8 mtm -90.0 52.3 2.25 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.26 -0.9 . . . . 0.0 109.381 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.991 HG21 ' HB2' ' A' ' 55' ' ' MET . 15.1 t -166.74 62.31 0.09 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.258 -0.901 . . . . 0.0 109.49 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.986 ' HB2' ' CD2' ' A' ' 101' ' ' HIS . . . -87.02 -18.32 30.89 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.25 -0.906 . . . . 0.0 109.465 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -90.0 75.88 7.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.27 -0.894 . . . . 0.0 109.472 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -173.4 -103.14 0.16 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.529 ' C ' HD12 ' A' ' 87' ' ' LEU . 11.5 pt-20 -114.61 173.57 6.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.29 -1.123 . . . . 0.0 109.437 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.529 HD12 ' C ' ' A' ' 86' ' ' GLU . 5.1 mp -147.56 69.98 1.16 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.228 -0.92 . . . . 0.0 109.442 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -96.01 -80.61 0.42 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.258 -0.901 . . . . 0.0 109.497 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.462 ' O ' ' CB ' ' A' ' 93' ' ' SER . 0.0 OUTLIER -84.05 10.28 10.41 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.203 -0.935 . . . . 0.0 109.458 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.623 ' CD1' ' CE1' ' A' ' 101' ' ' HIS . 2.8 tt -74.32 -44.71 48.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.284 -0.885 . . . . 0.0 109.466 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.584 ' N ' HG23 ' A' ' 90' ' ' ILE . 1.2 tt0 -57.04 -60.35 3.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.282 -0.886 . . . . 0.0 109.48 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.46 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 7.8 mt-10 -62.98 -32.71 74.11 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.268 -0.895 . . . . 0.0 109.43 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.964 ' HA ' HD12 ' A' ' 96' ' ' LEU . 2.2 m -60.41 -23.8 64.66 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.202 -0.936 . . . . 0.0 109.484 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.833 ' HA ' ' HB3' ' A' ' 98' ' ' ALA . 16.5 tttt -66.38 -70.33 0.25 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -0.921 . . . . 0.0 109.475 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -54.0 -19.54 4.91 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.265 -0.897 . . . . 0.0 109.396 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.964 HD12 ' HA ' ' A' ' 93' ' ' SER . 46.4 mt -70.51 -62.33 1.43 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.257 -0.902 . . . . 0.0 109.505 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -175.32 31.41 0.09 OUTLIER Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.833 ' HB3' ' HA ' ' A' ' 94' ' ' LYS . . . -101.93 92.88 5.0 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.184 -1.186 . . . . 0.0 109.465 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.611 HD11 ' CG ' ' A' ' 77' ' ' ARG . 21.5 mt -45.5 -77.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.256 -0.903 . . . . 0.0 109.484 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.833 HG22 HG12 ' A' ' 79' ' ' ILE . 12.2 t -122.37 179.4 4.58 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.166 -0.959 . . . . 0.0 109.474 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.986 ' CD2' ' HB2' ' A' ' 83' ' ' ALA . 4.4 t60 -134.83 93.69 3.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.283 -0.886 . . . . 0.0 109.445 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.695 ' CD2' HD13 ' A' ' 111' ' ' ILE . 9.2 m-85 -82.77 154.42 24.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.215 -0.928 . . . . 0.0 109.486 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.855 ' HB2' ' HB3' ' A' ' 83' ' ' ALA . . . -129.88 -169.91 2.21 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.282 -0.886 . . . . 0.0 109.398 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.483 ' CG ' ' HA ' ' A' ' 105' ' ' PRO . 46.5 tttt -124.94 141.38 38.17 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.191 -0.943 . . . . 0.0 109.38 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.483 ' HA ' ' CG ' ' A' ' 104' ' ' LYS . 35.3 Cg_endo -78.07 139.04 54.24 Favored 'Cis proline' 0 C--N 1.311 -1.439 0 C-N-CA 123.383 -1.507 . . . . 0.0 110.332 0.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.44 ' HB3' ' O ' ' A' ' 103' ' ' ALA . 0.3 OUTLIER -105.8 173.24 6.39 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.318 -0.864 . . . . 0.0 109.563 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.7 t0 -112.28 125.15 53.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.336 -0.852 . . . . 0.0 109.491 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.65 ' CG2' HG21 ' A' ' 22' ' ' VAL . 15.1 mm -52.53 -20.59 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.0 109.437 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -75.25 -40.86 58.55 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.251 -0.906 . . . . 0.0 109.439 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.69 -31.06 66.37 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.218 -0.926 . . . . 0.0 109.502 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.695 HD13 ' CD2' ' A' ' 102' ' ' PHE . 28.7 mm -70.19 -53.76 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.331 -0.856 . . . . 0.0 109.508 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 108' ' ' ILE . 9.3 ptt180 -65.96 -29.18 69.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.88 . . . . 0.0 109.505 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -66.43 -51.54 55.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 0.0 109.434 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.575 ' O ' ' CD2' ' A' ' 118' ' ' TYR . . . -64.97 -33.86 77.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.28 -0.887 . . . . 0.0 109.489 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.775 HG22 HD21 ' A' ' 50' ' ' LEU . 55.1 t -68.8 -31.89 52.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.917 . . . . 0.0 109.502 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.1 mmmt -74.03 -46.22 44.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.318 -0.864 . . . . 0.0 109.463 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -61.5 -40.55 95.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.295 -0.878 . . . . 0.0 109.489 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' TYR . . . . . 0.575 ' CD2' ' O ' ' A' ' 114' ' ' ALA . 21.5 m-85 -68.85 -70.59 0.26 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.203 -0.936 . . . . 0.0 109.47 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.2 tp -90.13 112.55 53.08 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.235 -0.916 . . . . 0.0 109.427 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 118' ' ' TYR . 35.8 Cg_endo -77.97 134.89 13.56 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.388 2.059 . . . . 0.0 110.387 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.47 HD23 ' HA ' ' A' ' 121' ' ' LEU . 5.6 mt -89.83 164.64 14.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.53 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 121' ' ' LEU . 0.8 OUTLIER -46.62 172.49 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.208 -0.932 . . . . 0.0 109.424 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.7 p -50.63 114.61 1.19 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.22 -0.925 . . . . 0.0 109.47 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 94.1 m-20 . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.481 179.979 . . . . . . . . 0 0 . 1 stop_ save_